{"altmetric_id":5070298,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":4},"twitter":{"unique_users_count":4,"unique_users":["NatRevUrol","adnan_bakri","NumaleMedical","ChrisAsandra"],"posts_count":4}},"selected_quotes":["Using #testosterone level to guide ADT in prostate cancer patients to reduce cost and symptoms","#NEWinNRU Commentary on the use of testosterone-level-guided LHRH agonist ADT in men w advanced #ProstateCancer","#NEWinNRU Commentary on the use of testosterone-level-guided LHRH agonist ADT in men w advanced #ProstateCancer ^CT"],"citation":{"altmetric_jid":"4f6fa62f3cf058f610008260","authors":["Tsutomu Nishiyama","Tatsuhiko Hoshii"],"doi":"10.1038\/nrurol.2016.9","first_seen_on":"2016-02-01T12:06:41+00:00","funders":["niehs"],"issns":["1759-4820","1759-4812"],"journal":"Nature Reviews Urology","last_mentioned_on":1454681459,"links":["http:\/\/www.nature.com\/nrurol\/journal\/vaop\/ncurrent\/full\/nrurol.2016.9.html?platform=hootsuite","http:\/\/www.nature.com\/nrurol\/journal\/vaop\/ncurrent\/full\/nrurol.2016.9.html"],"pmid":"26813950","pubdate":"2016-01-27T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Prostate cancer","scheme":"npg"},{"name":"Hormonal therapies","scheme":"npg"},{"name":"Biomarkers","scheme":"npg"},{"name":"Medical research","scheme":"npg"},{"name":"Cancer therapeutic resistance","scheme":"npg"},{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"Prostate cancer: Testosterone-guided ADT for prostate cancer","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/prostate-cancer-testosteroneguided-adt-prostate-cancer"},"altmetric_score":{"score":2.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.75},"context_for_score":{"all":{"total_number_of_other_articles":7103144,"mean":6.3016585108842,"rank":2571763,"this_scored_higher_than_pct":63,"this_scored_higher_than":4508552,"rank_type":"exact","sample_size":7103144,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":320744,"mean":9.3514594426064,"rank":103127,"this_scored_higher_than_pct":67,"this_scored_higher_than":215840,"rank_type":"exact","sample_size":320744,"percentile":67},"this_journal":{"total_number_of_other_articles":1211,"mean":5.2795652892562,"rank":575,"this_scored_higher_than_pct":51,"this_scored_higher_than":629,"rank_type":"exact","sample_size":1211,"percentile":51},"similar_age_this_journal_3m":{"total_number_of_other_articles":64,"mean":7.0952380952381,"rank":42,"this_scored_higher_than_pct":32,"this_scored_higher_than":21,"rank_type":"exact","sample_size":64,"percentile":32}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Scientists":1,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":1,"Student  > Doctoral Student":1},"by_discipline":{"Medicine and Dentistry":1,"Chemistry":1}}},"geo":{"twitter":{"GB":1,"FR":1,"US":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/NatRevUrol\/statuses\/694129439765106688","license":"gnip","citation_ids":[5070298],"posted_on":"2016-02-01T12:05:29+00:00","author":{"name":"NatureReviewsUrology","url":"http:\/\/www.nature.com\/nrurol","image":"https:\/\/pbs.twimg.com\/profile_images\/1630686023\/nrurol_Twitter_logo_normal.jpg","description":"Urology news, conference tweets & editors' picks from Chief Ed Annette Fenner [AF] & Senior Eds Lou Stone [LS] and Clemens Thoma [CT]","id_on_source":"NatRevUrol","tweeter_id":"407730106","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":6684},"tweet_id":"694129439765106688"},{"url":"http:\/\/twitter.com\/adnan_bakri\/statuses\/694137162451816448","license":"gnip","rt":["NatRevUrol"],"citation_ids":[5070298],"posted_on":"2016-02-01T12:36:10+00:00","author":{"name":"Dr Adnan El Bakri","url":"https:\/\/www.linkedin.com\/in\/dr-adnan-el-bakri-404869a6\/","image":"https:\/\/pbs.twimg.com\/profile_images\/859110600110198784\/hKGP5BJg_normal.jpg","description":"MD,PhD candidate. Entrepreneur CEO @InnovSante. #Urology #Oncology #Surgery. VP @CNJChirurgiens. @KidneyCancer Fellow @CNRS. #DeepLearning #eHealth #BigData #AI","id_on_source":"adnan_bakri","tweeter_id":"325053866","geo":{"lt":49.25,"ln":4.03333,"country":"FR"},"followers":2136},"tweet_id":"694137162451816448"},{"url":"http:\/\/twitter.com\/NumaleMedical\/statuses\/695609291647139840","license":"gnip","citation_ids":[5070298],"posted_on":"2016-02-05T14:05:53+00:00","author":{"name":"NuMale Medical Ctr","url":"http:\/\/www.numalemedical.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3412108940\/af43c2733f33a037fe53fe4f5f0e0d9e_normal.jpeg","description":"Specializing in men's wellness and sexual health. Confidential treatments for erectile dysfunction and testosterone replacement therapy. info@numalemedical.com","id_on_source":"NumaleMedical","tweeter_id":"1287530310","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":152},"tweet_id":"695609291647139840"},{"url":"http:\/\/twitter.com\/ChrisAsandra\/statuses\/695610572730187776","license":"gnip","citation_ids":[5070298],"posted_on":"2016-02-05T14:10:59+00:00","author":{"name":"Christopher Asandra","url":"http:\/\/numale.com","image":"https:\/\/pbs.twimg.com\/profile_images\/706959817479327744\/SfsWjwZc_normal.jpg","description":"Dr. Christopher Asandra M.D. is the Chief Medical Officer at NuMale, a medical clinic offering customized bio-identical hormone and sexual dysfunction treatment","id_on_source":"ChrisAsandra","tweeter_id":"29794175","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":1166},"tweet_id":"695610572730187776"}]}}